Deepak Chadha - 24 Jan 2023 Form 4 Insider Report for Fresh Tracks Therapeutics, Inc.

Role
Chief R&D Officer and COO
Signature
/s/ Christine G. Long, Attorney-in-Fact for Deepak Chadha (power of attorney previously filed)
Issuer symbol
N/A
Transactions as of
24 Jan 2023
Net transactions value
$0
Form type
4
Filing time
26 Jan 2023, 17:48:17 UTC
Previous filing
09 May 2022
Next filing
11 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FRTX Restricted Stock Units Award $0 +35,000 $0.000000 35,000 24 Jan 2023 Common Stock 35,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of issuer common stock upon settlement.
F2 The restricted stock units vest in full on the first anniversary of the grant date.